Certoparin

This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.

Identification

Name
Certoparin
Accession Number
DB09261
Description

Certoparin is part of the heparins of low molecular weight that presents high activity against the coagulation factor Xa. It is normally used to prevent deep venous thrombosis.

Type
Small Molecule
Groups
Approved, Investigational
Synonyms
Not Available

Pharmacology

Indication

Used in the prevention and treatment of venous thromboembolism (deep vein thrombosis and pulmonary embolism) and in the treatment of myocardial infarction.

Contraindications & Blackbox Warnings
Learn about our commercial Contraindications & Blackbox Warnings data.
Learn More
Pharmacodynamics
Not Available
Mechanism of action
Not Available
Absorption
Not Available
Volume of distribution
Not Available
Protein binding
Not Available
Metabolism
Not Available
Route of elimination
Not Available
Half-life
Not Available
Clearance
Not Available
Adverse Effects
Learn about our commercial Adverse Effects data.
Learn More
Toxicity
Not Available
Affected organisms
Not Available
Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
DrugInteraction
AcebutololThe risk or severity of hyperkalemia can be increased when Acebutolol is combined with Certoparin.
AceclofenacThe risk or severity of hyperkalemia can be increased when Aceclofenac is combined with Certoparin.
AcemetacinThe risk or severity of hyperkalemia can be increased when Certoparin is combined with Acemetacin.
Acetylsalicylic acidThe risk or severity of hyperkalemia can be increased when Acetylsalicylic acid is combined with Certoparin.
AlclofenacThe risk or severity of hyperkalemia can be increased when Certoparin is combined with Alclofenac.
AliskirenThe risk or severity of hyperkalemia can be increased when Aliskiren is combined with Certoparin.
AmilorideThe risk or severity of hyperkalemia can be increased when Amiloride is combined with Certoparin.
AminophenazoneThe risk or severity of hyperkalemia can be increased when Aminophenazone is combined with Certoparin.
AmiodaroneThe risk or severity of hyperkalemia can be increased when Amiodarone is combined with Certoparin.
AmlodipineThe risk or severity of hyperkalemia can be increased when Amlodipine is combined with Certoparin.
Additional Data Available
  • Extended Description
    Extended Description

    Extended description of the mechanism of action and particular properties of each drug interaction.

    Learn more
  • Severity
    Severity

    A severity rating for each drug interaction, from minor to major.

    Learn more
  • Evidence Level
    Evidence Level

    A rating for the strength of the evidence supporting each drug interaction.

    Learn more
  • Action
    Action

    An effect category for each drug interaction. Know how this interaction affects the subject drug.

    Learn more
Food Interactions
  • Avoid herbs and supplements with anticoagulant/antiplatelet activity. Examples include garlic, ginger, bilberry, danshen, piracetam, and ginkgo biloba.

Products

International/Other Brands
Embolex / Sandoparin

Categories

Drug Categories
Classification
Not classified

Chemical Identifiers

UNII
V72OT3K19I
CAS number
Not Available

References

General References
Not Available
PubChem Substance
347910425
RxNav
152610
Wikipedia
Certoparin_sodium

Clinical Trials

Clinical Trials
PhaseStatusPurposeConditionsCount
4Unknown StatusTreatmentHeparin Induced Thrombocytopenia (HIT)1
3CompletedPreventionRenal Dialysis1
3CompletedPreventionSystemic Embolism1
3CompletedPreventionThromboembolism1
3CompletedTreatmentPersistent Nonvalvular Atrial Fibrillation1
3TerminatedTreatmentNeoplasms / Venous Thromboembolism1
1, 2CompletedTreatmentImpaired kidney function1

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage Forms
FormRouteStrength
Injection, solutionParenteral3000 IE
Injection, solutionParenteral8000 IE
Prices
Not Available
Patents
Not Available

Properties

State
Solid
Experimental Properties
Not Available
Predicted Properties
Not Available
Predicted ADMET Features
Not Available

Spectra

Mass Spec (NIST)
Not Available
Spectra
Not Available

Drug created on October 26, 2015 11:10 / Updated on July 10, 2020 21:43

Logo pink
Are you a
new drug developer?
Contact us to learn more about our customized products and solutions.
Logo pink
Stay in the know!
As part of our commitment to providing the most up-to-date drug information, we will be releasing #DrugBankUpdates with our newly added curated drug pages.
#DrugBankUpdates